GLP-1 Market Trends The shift from injectables to oral GLP-1 formulations, like recent FDA approvals and even expansions, is lowering barriers to entry
PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 150+ genetic insights, including key variants like GIPR rs1800437, to reveal your individual therapeutic potential
The resulting downstream effects include decreased osteoclast-mediated bone resorption, improved low-density lipoprotein clearance, and modulation of hypothalamic thermoregulatory centers, translating to clinical relief of vasomotor instability
Obesity, a pervasive global health challenge, transcends borders, impacting millions with profound consequences to their well-being and quality of life
In an interview, Lurie said allowing peptides on the market without clinical testing poses a profound threat to FDAs decades-old system for vetting drugs
People lost an average of 15% and up to 22.5% of their body weight, respectively